A potential therapeutic effect of saikosaponin C as a novel dual-target anti-Alzheimer agent

Tae Ho Lee, Sungha Park, Mi Hyeon You, Ji Hong Lim, Sang Hyun Min, Byeong Mo Kim

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Alzheimer's disease (AD) is a chronic neurodegenerative disease and the risk of developing it increases with advancing age. In this study, we investigated the protective effects of saikosaponin C (SSc), one of the main bioactive components produced by the traditional Chinese herb, radix bupleuri, the root of Bupleurum falcatum, against AD in various neuronal models. Interestingly, we found that SSc has dual effects on AD by targeting amyloid beta (Aβ) and tau, two key proteins in AD. SSc significantly suppressed the release of both Aβ peptides 1-40 and 1-42 into cell culture supernatants, though it does not affect BACE1 activity and expression. SSc also inhibited abnormal tau phosphorylation at multiple AD-related residues. Moreover, SSc seems to have beneficial effects on cellular tau function; it accelerated nerve growth factor-mediated neurite outgrowth and increased the assembly of microtubules. In addition, SSc increased synaptic marker proteins such as synaptophysin and PSD-95. Considering its various biological activities, our results suggest that SSc might be a novel therapeutic tool for treating human AD and other neurodegenerative diseases.

Original languageEnglish
Pages (from-to)1232-1245
Number of pages14
JournalJournal of Neurochemistry
Volume136
Issue number6
DOIs
Publication statusPublished - 2016 Mar 1

Fingerprint

Therapeutic Uses
Alzheimer Disease
Neurodegenerative diseases
Neurodegenerative Diseases
Bupleurum
Synaptophysin
Phosphorylation
Nerve Growth Factor
Bioactivity
saikosaponin
Cell culture
Amyloid
Microtubules
Proteins
Chronic Disease
Cell Culture Techniques
Peptides

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Lee, Tae Ho ; Park, Sungha ; You, Mi Hyeon ; Lim, Ji Hong ; Min, Sang Hyun ; Kim, Byeong Mo. / A potential therapeutic effect of saikosaponin C as a novel dual-target anti-Alzheimer agent. In: Journal of Neurochemistry. 2016 ; Vol. 136, No. 6. pp. 1232-1245.
@article{d2bfc06487db4b22b677f548ee2928f4,
title = "A potential therapeutic effect of saikosaponin C as a novel dual-target anti-Alzheimer agent",
abstract = "Alzheimer's disease (AD) is a chronic neurodegenerative disease and the risk of developing it increases with advancing age. In this study, we investigated the protective effects of saikosaponin C (SSc), one of the main bioactive components produced by the traditional Chinese herb, radix bupleuri, the root of Bupleurum falcatum, against AD in various neuronal models. Interestingly, we found that SSc has dual effects on AD by targeting amyloid beta (Aβ) and tau, two key proteins in AD. SSc significantly suppressed the release of both Aβ peptides 1-40 and 1-42 into cell culture supernatants, though it does not affect BACE1 activity and expression. SSc also inhibited abnormal tau phosphorylation at multiple AD-related residues. Moreover, SSc seems to have beneficial effects on cellular tau function; it accelerated nerve growth factor-mediated neurite outgrowth and increased the assembly of microtubules. In addition, SSc increased synaptic marker proteins such as synaptophysin and PSD-95. Considering its various biological activities, our results suggest that SSc might be a novel therapeutic tool for treating human AD and other neurodegenerative diseases.",
author = "Lee, {Tae Ho} and Sungha Park and You, {Mi Hyeon} and Lim, {Ji Hong} and Min, {Sang Hyun} and Kim, {Byeong Mo}",
year = "2016",
month = "3",
day = "1",
doi = "10.1111/jnc.13515",
language = "English",
volume = "136",
pages = "1232--1245",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "6",

}

A potential therapeutic effect of saikosaponin C as a novel dual-target anti-Alzheimer agent. / Lee, Tae Ho; Park, Sungha; You, Mi Hyeon; Lim, Ji Hong; Min, Sang Hyun; Kim, Byeong Mo.

In: Journal of Neurochemistry, Vol. 136, No. 6, 01.03.2016, p. 1232-1245.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A potential therapeutic effect of saikosaponin C as a novel dual-target anti-Alzheimer agent

AU - Lee, Tae Ho

AU - Park, Sungha

AU - You, Mi Hyeon

AU - Lim, Ji Hong

AU - Min, Sang Hyun

AU - Kim, Byeong Mo

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Alzheimer's disease (AD) is a chronic neurodegenerative disease and the risk of developing it increases with advancing age. In this study, we investigated the protective effects of saikosaponin C (SSc), one of the main bioactive components produced by the traditional Chinese herb, radix bupleuri, the root of Bupleurum falcatum, against AD in various neuronal models. Interestingly, we found that SSc has dual effects on AD by targeting amyloid beta (Aβ) and tau, two key proteins in AD. SSc significantly suppressed the release of both Aβ peptides 1-40 and 1-42 into cell culture supernatants, though it does not affect BACE1 activity and expression. SSc also inhibited abnormal tau phosphorylation at multiple AD-related residues. Moreover, SSc seems to have beneficial effects on cellular tau function; it accelerated nerve growth factor-mediated neurite outgrowth and increased the assembly of microtubules. In addition, SSc increased synaptic marker proteins such as synaptophysin and PSD-95. Considering its various biological activities, our results suggest that SSc might be a novel therapeutic tool for treating human AD and other neurodegenerative diseases.

AB - Alzheimer's disease (AD) is a chronic neurodegenerative disease and the risk of developing it increases with advancing age. In this study, we investigated the protective effects of saikosaponin C (SSc), one of the main bioactive components produced by the traditional Chinese herb, radix bupleuri, the root of Bupleurum falcatum, against AD in various neuronal models. Interestingly, we found that SSc has dual effects on AD by targeting amyloid beta (Aβ) and tau, two key proteins in AD. SSc significantly suppressed the release of both Aβ peptides 1-40 and 1-42 into cell culture supernatants, though it does not affect BACE1 activity and expression. SSc also inhibited abnormal tau phosphorylation at multiple AD-related residues. Moreover, SSc seems to have beneficial effects on cellular tau function; it accelerated nerve growth factor-mediated neurite outgrowth and increased the assembly of microtubules. In addition, SSc increased synaptic marker proteins such as synaptophysin and PSD-95. Considering its various biological activities, our results suggest that SSc might be a novel therapeutic tool for treating human AD and other neurodegenerative diseases.

UR - http://www.scopus.com/inward/record.url?scp=84959914000&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959914000&partnerID=8YFLogxK

U2 - 10.1111/jnc.13515

DO - 10.1111/jnc.13515

M3 - Article

AN - SCOPUS:84959914000

VL - 136

SP - 1232

EP - 1245

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 6

ER -